Cardiology IT Workflow Solutions Business Research Report 2024: Rising Global Burden of Cardiovascular Diseases, Despite Efforts Aimed at Prevention to Spur Growth - Forecast to 2030
September 20, 2024 07:15 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Cardiology IT Workflow Solutions - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Angina Global Market Report 2024: A $13.61 Billion Market in 2028, Registering a Compound Annual Growth Rate (CAGR) of 6.2%
September 04, 2024 09:26 ET
|
Research and Markets
Dublin, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The "Angina Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The angina market size has grown strongly in recent years, from...
US Cardiologists Industry Analysis Trends and Forecasts 2024-2029: Rising Obesity and Heart Disease Rates Among U.S. Population Heighten Need for Cardiologist Care
August 27, 2024 04:01 ET
|
Research and Markets
Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Cardiologists in the US - Market Size, Industry Analysis, Trends and Forecasts (2024-2029)" report has been added to ResearchAndMarkets.com's...
U.S. Cardiology Procedures Market Analysis Report 2024-2030: Interventional Procedures, Peripheral Vascular Procedures, Heart Rhythm Management Procedures Size, Share & Trends
July 11, 2024 10:41 ET
|
Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "U.S. Cardiology Procedures Market Size, Share & Trends Analysis Report by Procedures (Interventional Procedures, Peripheral Vascular Procedures,...
MEACOR Secures $15 Million in Series A Funding to Advance Innovative Transcatheter Heart Valve Repair Technology
May 14, 2024 15:19 ET
|
Meacor inc.
MEACOR Secures $15 Million in Series A Funding to Advance Innovative Transcatheter Heart Valve Repair Technology
HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
April 04, 2024 07:30 ET
|
Avricore Health Inc.
Avriciore's HelathTab platform for point-of-care testing in pharmacy expands Rexall locations.
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 18, 2024 16:05 ET
|
Tenaya Therapeutics, Inc.
Initial Data from Ongoing MyPeak™-1 Phase 1b of TN-201 for MYBPC3-associated HCM Expected in Second Half of 2024 On Track to Dose First Patient in RIDGE™-1Phase 1b Clinical Trial of TN-401 for...
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
March 18, 2024 08:30 ET
|
Tenaya Therapeutics, Inc.
TN-401 AAV9-Based Gene Therapy Being Developed to Treat the Underlying Cause of PKP2-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) PKP2 Gene Replacement Therapy Normalized Heart...
Global Cardiology IT Workflow Solutions Research Report 2024: Market to Reach $1.8 Billion by 2030 - Artificial Intelligence (AI) to Revolutionize Cardiology Workflow Management
March 01, 2024 06:16 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Cardiology IT Workflow Solutions - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cardiology IT...
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
February 27, 2024 16:30 ET
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...